Literature DB >> 23353602

Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.

Ann D Cohen1, Wenzhu Mowrey, Lisa A Weissfeld, Howard J Aizenstein, Eric McDade, James M Mountz, Robert D Nebes, Judith A Saxton, Beth Snitz, Steven Dekosky, Jeff Williamson, Oscar L Lopez, Julie C Price, Chester A Mathis, William E Klunk.   

Abstract

UNLABELLED: An important research application of amyloid imaging with positron emission tomography (PET) is detection of the earliest evidence of fibrillar amyloid-beta (Aβ) deposition. Use of amyloid PET for this purpose, requires a reproducible method for defining a cutoff that separates individuals with no significant Aβ deposition from those in which Aβ deposition has begun. We previously reported the iterative outlier approach (IO) for the analysis of Pittsburgh Compound-B (PiB) PET data. Developments in amyloid imaging since the initial report of IO have led us to re-examine the generalizability of this method. IO was developed using full-dynamic atrophy-corrected PiB PET data obtained from a group of control subjects with a fairly distinct separation between PiB-positive [PiB(+)] and PiB-negative [PiB(-)] subjects.
METHODS: We tested the performance of IO using late-summed tissue ratio data with atrophy correction or with an automated template method without atrophy correction and tested the robustness of the method when applied to a cohort of older subjects in which separation between PiB(+) and PiB(-) subjects was not so distinct.
RESULTS: The IO method did not perform consistently across analyses and performed particularly poorly when separation was less clear. We found that a sparse k-means (SKM) cluster analysis approach performed significantly better; performing more consistently across methods and subject cohorts. We also compared SKM to a consensus visual read approach and found very good correspondence.
CONCLUSION: The visual read and SKM methods, applied together, may optimize the identification of early Aβ deposition. These methods have the potential to provide a standard approach to the detection of PiB-positivity that is generalizable across centers.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353602      PMCID: PMC3605888          DOI: 10.1016/j.neuroimage.2013.01.015

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  37 in total

1.  [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Authors:  M A Mintun; G N Larossa; Y I Sheline; C S Dence; S Y Lee; R H Mach; W E Klunk; C A Mathis; S T DeKosky; J C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

2.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Authors:  Keith A Johnson; Matt Gregas; John A Becker; Catherine Kinnecom; David H Salat; Erin K Moran; Erin E Smith; Jonathan Rosand; Dorene M Rentz; William E Klunk; Chester A Mathis; Julie C Price; Steven T Dekosky; Alan J Fischman; Steven M Greenberg
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

3.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Authors:  E C Mormino; J T Kluth; C M Madison; G D Rabinovici; S L Baker; B L Miller; R A Koeppe; C A Mathis; M W Weiner; W J Jagust
Journal:  Brain       Date:  2008-11-28       Impact factor: 13.501

4.  Sparse Clustering with Resampling for Subject Classification in PET Amyloid Imaging Studies.

Authors:  Wenzhu Bi; George C Tseng; Lisa A Weissfeld; Julie C Price
Journal:  IEEE Nucl Sci Symp Conf Rec (1997)       Date:  2011-10

5.  Cognition, glucose metabolism and amyloid burden in Alzheimer's disease.

Authors:  Ansgar J Furst; Gil D Rabinovici; Ara H Rostomian; Tyler Steed; Adi Alkalay; Caroline Racine; Bruce L Miller; William J Jagust
Journal:  Neurobiol Aging       Date:  2010-04-24       Impact factor: 4.673

6.  In vivo assessment of amyloid-β deposition in nondemented very elderly subjects.

Authors:  Chester A Mathis; Lewis H Kuller; William E Klunk; Beth E Snitz; Julie C Price; Lisa A Weissfeld; Bedda L Rosario; Brian J Lopresti; Judith A Saxton; Howard J Aizenstein; Eric M McDade; M Ilyas Kamboh; Steven T DeKosky; Oscar L Lopez
Journal:  Ann Neurol       Date:  2013-04-17       Impact factor: 10.422

7.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

8.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

9.  Frequent amyloid deposition without significant cognitive impairment among the elderly.

Authors:  Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk
Journal:  Arch Neurol       Date:  2008-11

10.  Cognition, reserve, and amyloid deposition in normal aging.

Authors:  Dorene M Rentz; Joseph J Locascio; John A Becker; Erin K Moran; Elisha Eng; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

View more
  53 in total

1.  Arterial stiffness and β-amyloid progression in nondemented elderly adults.

Authors:  Timothy M Hughes; Lewis H Kuller; Emma J M Barinas-Mitchell; Eric M McDade; William E Klunk; Ann D Cohen; Chester A Mathis; Steven T Dekosky; Julie C Price; Oscar L Lopez
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

2.  Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease.

Authors:  Andrei G Vlassenko; Lena McCue; Mateusz S Jasielec; Yi Su; Brian A Gordon; Chengjie Xiong; David M Holtzman; Tammie L S Benzinger; John C Morris; Anne M Fagan
Journal:  Ann Neurol       Date:  2016-07-25       Impact factor: 10.422

3.  Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study.

Authors:  Beth E Snitz; Oscar L Lopez; Eric McDade; James T Becker; Ann D Cohen; Julie C Price; Chester A Mathis; William E Klunk
Journal:  J Alzheimers Dis       Date:  2015-09-24       Impact factor: 4.472

4.  Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.

Authors:  Sigan L Hartley; Benjamin L Handen; Darlynne Devenny; Iulia Mihaila; Regina Hardison; Patrick J Lao; William E Klunk; Peter Bulova; Sterling C Johnson; Bradley T Christian
Journal:  Neurobiol Aging       Date:  2017-06-02       Impact factor: 4.673

5.  Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Authors:  Brian J Lopresti; Elizabeth M Campbell; Zheming Yu; Stewart J Anderson; Ann D Cohen; Davneet S Minhas; Beth E Snitz; Sarah K Royse; Carl R Becker; Howard J Aizenstein; Chester A Mathis; Oscar L Lopez; William E Klunk; Dana L Tudorascu
Journal:  Neurobiol Aging       Date:  2020-05-31       Impact factor: 4.673

6.  Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET.

Authors:  Yin J Chen; Bedda L Rosario; Wenzhu Mowrey; Charles M Laymon; Xueling Lu; Oscar L Lopez; William E Klunk; Brian J Lopresti; Chester A Mathis; Julie C Price
Journal:  J Nucl Med       Date:  2015-06-04       Impact factor: 10.057

7.  Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.

Authors:  Wai-Ying Wendy Yau; Dana L Tudorascu; Eric M McDade; Snezana Ikonomovic; Jeffrey A James; Davneet Minhas; Wenzhu Mowrey; Lei K Sheu; Beth E Snitz; Lisa Weissfeld; Peter J Gianaros; Howard J Aizenstein; Julie C Price; Chester A Mathis; Oscar L Lopez; William E Klunk
Journal:  Lancet Neurol       Date:  2015-06-29       Impact factor: 44.182

8.  Relationships Between Executive Control Circuit Activity, Amyloid Burden, and Education in Cognitively Healthy Older Adults.

Authors:  Helmet T Karim; Dana L Tudorascu; Ann Cohen; Julie C Price; Brian Lopresti; Chester Mathis; William Klunk; Beth E Snitz; Howard J Aizenstein
Journal:  Am J Geriatr Psychiatry       Date:  2019-07-19       Impact factor: 4.105

9.  Amyloid deposition is associated with different patterns of hippocampal connectivity in men versus women.

Authors:  Minjie Wu; Rebecca C Thurston; Dana L Tudorascu; Helmet T Karim; Chester A Mathis; Brian J Lopresti; M Ilyas Kamboh; Ann D Cohen; Beth E Snitz; William E Klunk; Howard J Aizenstein
Journal:  Neurobiol Aging       Date:  2018-12-01       Impact factor: 4.673

10.  Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.

Authors:  Sigan L Hartley; Benjamin L Handen; Darlynne A Devenny; Regina Hardison; Iulia Mihaila; Julie C Price; Annie D Cohen; William E Klunk; Marsha R Mailick; Sterling C Johnson; Bradley T Christian
Journal:  Brain       Date:  2014-07-02       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.